Neonatal Hypoxia/Ischemia Is Associated With Decreased Inflammatory Mediators After Erythropoietin Administration

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Stroke

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.STR.0000173406.04891.8cPMID 16040592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• treatment of

  2005cited by this paper
• Treatment of Stroke With Erythropoietin Enhances Neurogenesis and Angiogenesis and Improves Neurological Function in Rats

  2004cited by this paper
• Erythropoietin as an antiapoptotic, tissue-protective cytokine

  2004cited by this paper
• Erythropoietin in the brain: can the promise to protect be fulfilled?

  2004cited by this paper
• Erythropoietin as a Tissue-Protective Cytokine in Brain Injury: What Do We Know and Where Do We Go?

  2004cited by this paper
• Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats.

  2004cited by this paper
• Mechanisms of Erythropoietin-induced Brain Protection in Neonatal Hypoxia-Ischemia Rat Model

  2004cited by this paper
• Treatment of Stroke With Erythropoietin Enhances Neurogenesis and Angiogenesis and Improves Neurological Function in Rats

  2004cited by this paper
• Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis

  2003cited by this paper
• Neuroprotective Effect of Erythropoietin on Hypoxic-Ischemic Brain Injury in Neonatal Rats

  2003cited by this paper
• Interleukin-18 Involvement in Hypoxic–Ischemic Brain Injury

  2002cited by this paper
• Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up‐regulating Bcl‐xL expression

  2002cited by this paper
• Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants.

  2002cited by this paper
• Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

  2002cited by this paper
• Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model.

  2002cited by this paper
• Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: current concepts.

  2002cited by this paper
• Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

  2001cited by this paper
• Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity.

  2000cited by this paper
• Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

  2000cited by this paper
• Chronic myeloid leukemia in first chronic phase not responding to α-interferon: outcome and prognostic factors after autologous transplantation

  1999cited by this paper
• Chemokine and Inflammatory Cell Response to Hypoxia-Ischemia in Immature Rats

  1999cited by this paper
• Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury.

  1998cited by this paper
• Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy.

  1997cited by this paper
• Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy

  1997cited by this paper
• Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death.

  1996cited by this paper
• Enhanced Expression of Interleukin (IL)-1 and IL-6 Messenger RNA and Bioactive Protein after Hypoxia-Ischemia in Neonatal Rats

  1996cited by this paper
• Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats.

  1995cited by this paper
• The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia.

  1994cited by this paper

• Preconditioning and Posttreatment Strategies in Neonatal Hypoxic-Ischemic Encephalopathy: Recent Advances and Clinical Challenges

  2025cites this paper
• The use of erythropoietin and magnesium sulphate for the management of hypoxic-ischaemic encephalopathy in Lagos, Nigeria: A randomized control trial

  2025cites this paper
• On target dosing: erythropoietin exposure in neonates with hypoxic-ischemic encephalopathy in the HEAL trial

  2024cites this paper
• Pipeline to Neonatal Clinical Transformation: The Importance of Preclinical Data.

  2024cites this paper
• Neuroprotection for neonatal hypoxic–ischemic encephalopathy: A review of novel therapies evaluated in clinical studies

  2024cites this paper
• Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy

  2023cites this paper
• Anemia, Iron Supplementation, and the Brain.

  2023cites this paper
• Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series)

  2023cites this paper
• Eumelanin decorated poly(lactic acid) electrospun substrates as a new strategy for spinal cord injury treatment.

  2023cites this paper
• Neonatal Hypoxic-Ischemic Encephalopathy: Perspectives of Neuroprotective and Neuroregenerative Treatments.

  2022cites this paper
• Toxic and Nutritional Optic Neuropathies—An Updated Mini-Review

  2022cites this paper
• Inhibition of NOD1 Attenuates Neonatal Hypoxia-Ischemia Induced Long-Term Cognitive Impairments in Mice Through Modulation of Autophagy-Related Proteins

  2021cites this paper
• Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial

  2021cites this paper
• Hypothermia modulates myeloid cell polarization in neonatal hypoxic–ischemic brain injury

  2021cites this paper
• A Brief Review on Erythropoietin and Mesenchymal Stem Cell Therapies for Paediatric Neurological Disorders

  2021cites this paper
• Challenges in developing therapeutic strategies for mild neonatal encephalopathy

  2021cites this paper
• The role of G-CSF neuroprotective effects in neonatal hypoxic-ischemic encephalopathy (HIE): current status

  2021cites this paper
• Altered Cytokine Endotoxin Responses in Neonatal Encephalopathy Predict MRI Outcomes

  2021cites this paper
• NDT_A_314884 2659..2669

  2021cites this paper
• Traumatic Cranial Neuropathies

  2020cites this paper
• GW0742 activates miR‐17‐5p and inhibits TXNIP/NLRP3‐mediated inflammation after hypoxic‐ischaemic injury in rats and in PC12 cells

  2020cites this paper
• Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer’s Disease

  2020cites this paper
• Impact of Erythropoietin in the management of Hypoxic Ischaemic Encephalopathy in resource-constrained settings: protocol for a randomized control trial

  2020cites this paper
• Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research

  2020cites this paper
• G-CSF Attenuates Neuroinflammation and Neuronal Apoptosis via the mTOR/p70SK6 Signaling Pathway in Neonatal Hypoxia-Ischemia Rat Model.

  2020cites this paper
• Reply.

  2020cites this paper
• How Near Are We to Using Darbepoetin or Erythropoietin as Neuroprotective Agents for Perinatal Hypoxic-Ischemic Encephalopathy?

  2019cites this paper
• Potential biomarkers for neuroinflammation and neurodegeneration at short and long term after neonatal hypoxic-ischemic insult in rat

  2019cites this paper
• [Hypoxic-ischemic brain damage in premature newborns].

  2019cites this paper
• Efficacy and safety of erythropoietin in patients with traumatic brain injury: A systematic review and meta-analysis.

  2019cites this paper
• Visual Outcomes of Adding Erythropoietin to Methylprednisolone for Treatment of Retrobulbar Optic Neuritis

  2019cites this paper
• Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis

  2019cites this paper
• Erythropoietin reduces nerve demyelination, neuropathic pain behavior and microglial MAPKs activation through erythropoietin receptors on Schwann cells in a rat model of peripheral neuropathy

  2018cites this paper
• Erythropoietin in Treatment of Methanol Optic Neuropathy

  2018cites this paper
• Regarding True Lambdoid Synostosis: Long-Term Results of Surgical and Conservative Therapy

  2018cites this paper
• Current and Emerging Therapies in the Management of Hypoxic Ischemic Encephalopathy in Neonates

  2018cites this paper
• Role of Human Recombinant Erythropoietin (rHuEPO) in Perinatal Asphyxia-a randomized controlled trial

  2018cites this paper
• Regarding True Lambdoid Synostosis: Long-Term Results of Surgical and Conservative Therapy

  2018cites this paper
• Regarding True Lambdoid Synostosis: Long-Term Results of Surgical and Conservative Therapy

  2018cites this paper
• Regarding True Lambdoid Synostosis: Long-Term Results of Surgical and Conservative Therapy

  2018cites this paper
• The Synergistic Combination of Everolimus and Paroxetine Exerts Post-ischemic Neuroprotection In Vitro

  2018cites this paper
• The fetus at the tipping point: modifying the outcome of fetal asphyxia

  2018cites this paper
• Systematic review seeking erythropoietin role for neuroprotection in neonates with hypoxic ischemic encephalopathy: presently where do we stand

  2018cites this paper
• Stroke in the Newborn

  2018cites this paper
• Recombinant Human Erythropoietin Protects Against Hippocampal Damage in Developing Rats with Seizures by Modulating Autophagy via the S6 Protein in a Time-Dependent Manner

  2017cites this paper
• Insights Into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia

  2017cites this paper
• Subcellular Energetics and Metabolism: A Cross-Species Framework

  2017cites this paper
• Erythropoietin and Brain Magnetic Resonance Imaging Findings in Hypoxic‐Ischemic Encephalopathy: Volume of Acute Brain Injury and 1‐Year Neurodevelopmental Outcome

  2017cites this paper
• The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia

  2017cites this paper
• Effect of erythropoietin combined with hypothermia on serum tau protein levels and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy

  2017cites this paper
• Neuroprotection strategies for the newborn

  2017cites this paper
• Mitochondria, Bioenergetics and Excitotoxicity: New Therapeutic Targets in Perinatal Brain Injury

  2017cites this paper
• A comparison of the effectiveness of erythropoietin and dexamethasone therapy in Streptococcus pneumoniae induced meningitis in rabbits.

  2017cites this paper
• Home sweet home: the neural stem cell niche throughout development and after injury

  2017cites this paper
• 19 – Hypoxic-Ischemic Brain Injury in the Term Newborn

  2017cites this paper
• Effects of erythropoietin on neonatal hypoxia-ischemia brain injury in rat model.

  2017cites this paper
• High-Dose Erythropoietin Population Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia

  2017cites this paper
• Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms

  2017cites this paper
• Molecular chaperones and hypoxic-ischemic encephalopathy

  2017cites this paper
• Perinatal brain damage: The term infant

  2016cites this paper
• Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

  2016cites this paper
• Erythropoietin Ameliorates Neonatal Hypoxia-Ischemia-Induced Neurobehavioral Deficits, Neuroinflammation, and Hippocampal Injury in the Juvenile Rat

  2016cites this paper
• Perinatal Asphyxia and Erythropoietin and VEGF: Serial Serum and Cerebrospinal Fluid Responses

  2016cites this paper
• Erythropoietin Pathway: A Potential Target for the Treatment of Depression

  2016cites this paper
• High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial

  2016cites this paper
• Systemic endogenous erythropoietin and associated disorders in extremely preterm newborns

  2016cites this paper
• Neonatal brain injury as a consequence of insufficient cerebral oxygenation.

  2016cites this paper
• The Neuroprotective Effect of Erythropoietin in Rat Hippocampus in an Endotoxic Shock Model.

  2016cites this paper
• Levodopa and Other Pharmacologic Interventions in Ischemic and Traumatic Optic Neuropathies and Amblyopia

  2016cites this paper
• Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy

  2016cites this paper
• Cell based therapeutics for retinal degenerations

  2016cites this paper
• New Antioxidant Drugs for Neonatal Brain Injury

  2015cites this paper
• Hypoxic-ischemic encephalopathy: a review for the clinician.

  2015cites this paper
• Hypoxic-Ischemic EncephalopathyA Review for the Clinician

  2015cites this paper
• Erythropoietin: a novel therapy for hypoxic–ischaemic encephalopathy?

  2015cites this paper
• Effect of Sex and Age Interactions on Functional Outcome after Stroke

  2015cites this paper
• Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response

  2015cites this paper
• Neuroprotective Effects of Erythropoietin in Patients with Severe Closed Brain Injury.

  2015cites this paper
• Neuroprotective potential of erythropoietin in neonates; design of a randomized trial

  2015cites this paper
• Neuroinflammation and Neuroimmune Dysregulation after Acute Hypoxic-Ischemic Injury of Developing Brain

  2015cites this paper
• Erythropoietin in stroke therapy: friend or foe.

  2015cites this paper
• Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats

  2015cites this paper
• Hypoxic-IschemicEncephalopathy A Review for the Clinician

  2015cites this paper
• Neuroprotective agents for neonatal hypoxic-ischemic brain injury.

  2015cites this paper
• Neonatal hypoxic ischaemic encephalopathy: current and future treatment options

  2015cites this paper
• The potential of erythropoietin to treat asphyxia in newborns

  2014cites this paper
• New light on white matter damage of the premature brain: a neonatologist's point of view

  2014cites this paper
• Feasibility and safety of erythropoietin for neuroprotection after perinatal arterial ischemic stroke.

  2014cites this paper
• Erythropoietin protects newborn rat against sevoflurane‐induced neurotoxicity

  2014cites this paper
• New Antioxidant Drugs

  2014cites this paper
• Creatine monohydrate supplemented diets affect serum inflammatory cytokine levels (IL-6 and IL-18) in female albino mice following neonatal hypoxic ischemic encephalopathy.

  2014cites this paper
• Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.

  2014cites this paper
• Current and experimental pharmacological approaches in neonatal hypoxic- ischemic encephalopathy.

  2014cites this paper
• Hypoxic preconditioning protection is eliminated in HIF-1α knockout mice subjected to neonatal hypoxia-ischemia

  2014cites this paper
• Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.

  2014cites this paper
• Pharmacologic neuroprotective strategies in neonatal brain injury.

  2014cites this paper
• Perinatal and Prenatal Disorders

  2014cites this paper
• The Impact of Recombinant Human Erythropoietin Treatment on Motor Impairment in Rotenone-Induced Parkinsonism in Rats

  2014cites this paper
• Behavioral and Neuroanatomical Consequences of Neonatal Hypoxic Ischemic Injury, and the Therapeutic Effects of Neuroprotectants: An Animal Model

  2013influential citation
• Beyond Hypothermia: Alternative Therapies for Hypoxic Ischemic Encephalopathy

  2013cites this paper